top menu action banner

CABOZANIX (CABOZANTINIB) 60MG Tabs 30`S

Ksh 172,499

In Stock

  • Product Categories:

. WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR?

Cabozanix contains cabozantinib, a type of targeted cancer therapy called a tyrosine kinase inhibitor (TKI). Unlike traditional chemotherapy, which attacks all rapidly dividing cells, cabozantinib specifically blocks multiple protein signals (including MET, RET, VEGFR2, AXL, and others) that certain cancer cells depend on to grow new blood vessels (angiogenesis) and spread. Cabozanix is used to treat: advanced renal cell carcinoma (RCC) — the most common type of kidney cancer; hepatocellular carcinoma (HCC) — primary liver cancer (after sorafenib treatment); and differentiated thyroid cancer (DTC) that has spread and is no longer responding to radioactive iodine treatment.

 

3. HOW TO TAKE THIS MEDICINE

Take one 40 - 60 mg tablet ONCE DAILY at the same time each day. Take on an EMPTY STOMACH — do not eat for at least 2 hours before and at least 1 hour after taking the tablet. Swallow whole with water — do not crush or split. Do not eat grapefruit or drink grapefruit juice during treatment. When combined with nivolumab for kidney cancer, the dose is usually reduced to 40 mg once daily.

 

💡 PATIENT TIP:

Dose reductions are made in 20 mg steps (60 mg → 40 mg → 20 mg) for significant side effects. Hold for Grade 3 or intolerable Grade 2 toxicities; resume at reduced dose when resolved.

Permanently discontinue for Grade 4 events, blood clots in arteries (stroke, MI), GI perforation, or jaw bone death (ONJ).

No adjustment for mild/moderate liver impairment; severe liver disease: not recommended.

 

4. POSSIBLE SIDE EFFECTS

How Common?

Side Effects to Know About

Common (>1 in 10)

Diarrhoea (most common — affects most patients), fatigue, reduced appetite and weight loss, nausea, hand-foot skin reaction (painful redness and peeling on palms and soles), high blood pressure, mouth sores, hoarse voice, vomiting, constipation, abdominal pain

Less Common

Hair colour changes, muscle cramps, raised liver enzymes, underactive thyroid, protein in urine, headache, peripheral nerve tingling

Seek Medical Help

Severe hypertension / hypertensive crisis (stroke risk), arterial blood clots (heart attack, stroke), venous blood clots (DVT, pulmonary embolism), hole in gut wall (GI perforation — abdominal emergency), severe liver damage/liver failure, reversible brain swelling (PRES/RPLS), jawbone death (ONJ), impaired wound healing — do not have surgery while on treatment without careful planning.

 

5. WHO SHOULD NOT TAKE THIS MEDICINE

Known allergy to cabozantinib. Pregnancy (causes serious birth defects and can kill the fetus). Breastfeeding. Planned major surgery within 28 days.

 

IMPORTANT SAFETY INFORMATION:

HYPERTENSION: Your blood pressure must be controlled before starting. Monitor throughout treatment and treat promptly if it rises.

BLEEDING AND CLOTS: Report any signs of a blood clot or unusual bleeding immediately.

GI PERFORATION: Abdominal pain that gets suddenly worse may indicate a hole in the gut — a life-threatening emergency.

JAWBONE: Inform your dentist that you are on this medicine before any invasive dental work. Brush teeth gently and avoid unnecessary dental extractions.

WOUND HEALING: Cabozantinib must be stopped at least 28 days before any elective surgery.

CONTRACEPTION: Effective contraception is required during treatment and for at least 4 months after the last dose.

 

6. MEDICINES THAT INTERACT WITH THIS TREATMENT

CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, grapefruit): increase cabozantinib levels — reduce cabozantinib dose by 20 mg. CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's Wort): decrease levels — increase dose by 20 mg (max 80 mg). Anticoagulants (warfarin): careful monitoring needed. Avoid grapefruit.

 

7. HOW TO STORE THIS MEDICINE

Store below 25°C. Protect from light and moisture. Keep in original container. Keep out of reach of children.

 

8. PRESCRIPTION REQUIREMENT

Status

Prescription Only Medicine (POM) — Oncology Specialist Required

 

9. GUIDANCE FOR PATIENTS & CAREGIVERS

Take one tablet at the same time every day on an EMPTY STOMACH — nothing to eat for 2 hours before and 1 hour after taking it. Do not crush or split. Check your blood pressure regularly at home if possible. Report immediately: severe or sudden high blood pressure, chest pain, signs of a stroke (face drooping, arm weakness, speech difficulty), severe stomach pain, severe redness and peeling of hands and feet, jaw pain, or unusual bleeding. Do not eat grapefruit. Use effective contraception during and for 4 months after treatment. Do not take St John's Wort.

 

10. PHARMACIST & PRESCRIBER NOTES

Clinical Dispensing Notes

Oncology specialist prescription required. Standard dose: 60 mg (monotherapy RCC, HCC, DTC) or 40 mg (with nivolumab for RCC). EMPTY STOMACH critical for consistent absorption. CYP3A4 interactions are clinically significant — adjust dose with inhibitors (reduce 20 mg) or inducers (increase 20 mg). Monitor BP every cycle. Regular LFTs, CBC, urinalysis (proteinuria). Dental review before initiation (ONJ risk). Withhold 28 days perioperatively. Counsel on contraception (4 months post-treatment).

 

11. FREQUENTLY ASKED QUESTIONS

Q: What cancer does cabozantinib (Cabozanix) treat?

A: Cabozantinib is used to treat three types of cancer: advanced renal cell carcinoma (RCC — kidney cancer), hepatocellular carcinoma (HCC — primary liver cancer, after sorafenib treatment has stopped working), and differentiated thyroid cancer (DTC) that has spread and no longer responds to radioactive iodine.

Q: What is hand-foot skin reaction and how can I manage it?

A: Hand-foot skin reaction (HFSR or palmar-plantar erythrodysaesthesia) causes painful redness, swelling, blistering, and peeling on the palms of the hands and soles of the feet. It is one of the most common side effects of cabozantinib. Management includes: using thick moisturisers, wearing soft padded shoes, avoiding pressure on affected areas, and dose reduction if it becomes severe. Tell your oncology team early — they can help manage it effectively.

Q: Can I have surgery while taking Cabozanix?

A: Not without planning — cabozantinib impairs wound healing and must be stopped at least 28 days before any planned surgery. It can be restarted after your surgical wound has healed fully. This is important to prevent serious wound healing complications after surgery.

Q: Why does my doctor monitor my blood pressure so closely on Cabozanix?

A: Cabozantinib blocks the VEGFR pathway, which helps control blood vessel tone. This interference commonly raises blood pressure, sometimes to dangerous levels. Uncontrolled hypertension increases the risk of stroke and heart attack. Blood pressure monitoring at home and at each clinic visit allows early intervention.

Customer Feedback


Recently Viewed